Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:46:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed information about a clinical trial for propranolol and pembrolizumab in treating melanoma, while adding a new registry identifier and a revision update.
    Difference
    43%
    Check dated 2025-04-16T01:43:11.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 27, 2025, while a previous date of March 25, 2025, has been removed.
    Difference
    0.4%
    Check dated 2025-04-08T20:16:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T14:48:42.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The webpage has updated its date references, adding new future dates while removing older ones. The last update notice has also been modified to reflect an estimated posting.
    Difference
    2%
    Check dated 2025-03-03T22:18:32.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:45:20.000Z thumbnail image

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.